Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation.
Congenital toxoplasmosis usually results from acquired infection in non-immune pregnant women. However, severely HIV-infected women with a latent Toxoplasma infection can transmit the parasite as a result of reactivation. We report a case of toxoplasmic reactivation in an HIV-infected woman with moderate immunosuppression resulting in a severe congenital toxoplasmosis.
Bachmeyer
C
C
Service de Médecine Interne, CHU Tenon, 4 Rue de la Chine, 75020 Paris, France. claude.bachmeyer@tnn.ap-hop-paris.fr
Mouchnino
G
G
Thulliez
P
P
Blum
L
L
D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D015658:HIV Infections / Q000150:complications / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology*; D015597:Pregnancy Complications, Parasitic / Q000276:immunology*; D011739:Pyrimethamine / Q000008:administration & dosage; D012008:Recurrence; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000635:transmission; D014125:Toxoplasmosis, Congenital / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D014803:Vitamin B Complex / Q000008:administration & dosage
D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D014803:Vitamin B Complex; D002955:Leucovorin; D011739:Pyrimethamine